Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
47.83
-0.46 (-0.95%)
At close: Sep 25, 2025, 3:59 PM
47.00
-1.74%
After-hours: Sep 25, 2025, 05:24 PM EDT
-0.95% (1D)
| Bid | 47.76 |
| Market Cap | 5.72B |
| Revenue (ttm) | 85.74M |
| Net Income (ttm) | -606.31M |
| EPS (ttm) | -5.12 |
| PE Ratio (ttm) | -9.34 |
| Forward PE | -8.53 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 47.99 |
| Volume | 1,575,409 |
| Avg. Volume (20D) | 2,053,109 |
| Open | 48.02 |
| Previous Close | 48.29 |
| Day's Range | 47.22 - 48.54 |
| 52-Week Range | 29.31 - 59.39 |
| Beta | 0.62 |
| Ex-Dividend Date | n/a |
About CYTK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CYTK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CYTK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCytokinetics is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+0.65%
CYTK stock has given up its prior loss. Cytokineti...
Unlock content with
Pro Subscription
1 week ago
+0.65%
Cytokinetics shares are trading lower after the company announced a $550 million private offering of convertible notes.
